Werewolf Therapeutics, Inc.HOWLNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank64
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P64
Within normal range
vs 2Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q3 20250.05%
Q2 202519.97%
Q1 2025-31.81%
Q4 2024-15.32%
Q3 202412.18%
Q2 20247.88%
Q1 2024-222.14%
Q4 202335.62%
Q3 202333.09%
Q2 2023-10.30%
Q1 202318.74%
Q4 202224.58%
Q3 2022-1061.67%
Q2 202289.88%
Q1 2022-7.99%
Q4 2021-3.40%
Q3 2021-18.43%
Q2 2021-44.04%
Q1 2021-21.95%
Q4 2020-20.89%
Q3 2020-14.70%
Q2 2020-12.79%
Q1 20200.00%